United Kingdom· GB-APID-42601111000001104
Enspryng 120mg/1ml solution for injection pre-filled syringes
A satralizumab product containing satralizumab, registered in United Kingdom by Roche Products Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Satralizumab is registered in 13 of 19 countries.
Countries holding a registration under ATC L04AC19 (satralizumab), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Satralizumab · ATC L04AC19
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Satralizumab
- Manufacturer
- Roche Products Ltd
- Country
- United Kingdom (GB)
- ATC code
- L04AC19
- ATC class
- Satralizumab
- Defined daily dose
- 4.3 mg, P
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 2
- gtin7613326031837
- gtin07613326031837
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
115 interactions on record for satralizumab.
Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Satralizumab · interactions on record
115 records
- 35 severe
- 74 moderate
- 6 minor
Most severe, free to view
- CladribineL01BB04severe
- RituximabL01FA01severe
- RituximabL01XC02severe
- Talimogene laherparepvecL01XL02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Satralizumab in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaENSPRYNGRoche Registration GmbH, Grenzach-Wyhlen
- BelgiumEnspryng 120 mgRoche Registration
- PolandEnspryngRoche Registration GmbH
- SpainENSPRYNG 120 mg SOLUCION INYECTABLE EN JERINGA PRECARGADARoche Registration Gmbh
- SwedenEnspryng 120 mg Injektionsvätska, lösning i förfylld sprutaRoche Registration GmbH
- FinlandEnspryngRoche Registration GmbH
- Japanサトラリズマブ（遺伝子組換え）中外製薬
- United StatesEnspryngGenentech, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Enspryng, Enspryng Pre-Filled Pen Pre-Filled Pen
- Liechtenstein · Enspryng, Enspryng Pre-Filled Pen Pre-Filled Pen
- Norway · Enspryng, Enspryng Pre-Filled Pen Pre-Filled Pen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d1657d36-5e69-4e47-b4b7-de36be80d301 GET /v1/drugs/d1657d36-5e69-4e47-b4b7-de36be80d301?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "42601111000001104",
"desc": "Enspryng 120mg/1ml solution for injection pre-filled syringes (Roche Products Ltd)",
"form": "Solution for injection",
"vpid": "42626811000001106",
"source": "dmd",
"vtm_id": "897292004",
"strength": "120 mg",
"substance": "Satralizumab",
"ingredient": "Satralizumab",
"supplier_code": "2085201000001100"
}See everything about satralizumab.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.